There is a Corrigendum (June 2002) associated with this News and Views.
Not just research tools—proteasome inhibitors offer therapeutic promise
Alfred L. Goldberg1
& Kenneth Rock2
1
Department of Cell Biology Harvard Medical School Boston, Massachusetts, USA
2
Department of Pathology University of Massachusetts Medical Center Worcester, Massachusetts, USA
alfred_goldberg@hms.harvard.edu
Proteasome inhibitors have served as critical tools to investigate protein degradation in eukaryotic cells. Now, these inhibitors are proving effective in the treatment of cancer and inflammatory disorders, most recently in animal models of psoriasis.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
